查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873193

全球中心靜脈通路裝置市場

Central Venous Access Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球中心靜脈通路裝置市場預計2030年將達24億美元

全球中心靜脈通路裝置市場規模在2024年估計為18億美元，預計到2030年將達到24億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為4.8%。本報告分析的細分市場之一—藥物輸注應用，預計將以5.0%的複合年成長率成長，並在分析期間結束時達到10億美元。輸液和營養輸注應用細分市場預計在分析期間內將以5.1%的複合年成長率成長。

美國市場規模估計為4.784億美元，而中國市場預計將以7.4%的複合年成長率成長。

預計2024年，美國中心靜脈通路裝置市場規模將達到4.784億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5.355億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）將達到7.4%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為2.9%和3.8%。在歐洲，德國預計將以約3.4%的複合年成長率成長。

全球中心靜脈通路裝置市場－主要市場趨勢與促進因素概述

為什麼中心靜脈通路裝置在現代醫學中如此重要？

中心靜脈通路裝置（CVAD）已成為現代醫學中不可或缺的一部分，尤其適用於需要長期靜脈治療的患者，例如化療、透析和腸外營養。這些裝置包括插入鎖骨下靜脈或頸內靜脈等大靜脈的導管，能夠有效且穩定地將藥物、液體和其他療法直接輸送到血液中。對於接受癌症治療的患者，中央靜脈導管減少了反覆穿刺的需要，提供了更舒適且方便的解決方案。它們能夠輸送高濃度藥物，同時降低靜脈刺激的風險，這在加護治療環境中尤其重要。如今，中心靜脈導管的應用範圍已擴展到多種醫療領域，包括慢性病管理、急診護理和維生治療，使其成為現代醫療通訊協定中不可或缺的工具。

科技創新如何提高中心靜脈導管的安全性和有效性？

技術進步顯著改善了中心靜脈通路裝置的設計和功能，提高了病人安全性和臨床療效。其中一項最顯著的創新是抗菌和抗血栓塗層的研發，這有助於降低導管相關感染疾病和血栓的風險，而這些正是中心靜脈通路裝置最常見的併發症。此外，矽膠和聚氨酯等導管材料的進步使這些裝置更加柔韌耐用，最大限度地降低了靜脈損傷的風險，並延長了裝置的使用壽命。另一項關鍵創新是在導管插入過程中使用超音波引導，這顯著提高了中心靜脈通路裝置置入的準確性和安全性。該技術降低了動脈穿刺和氣胸等插入併發症的風險，同時縮短了手術時間。此外，整合感測器和即時監測功能的裝置的研發使醫護人員能夠更有效地追蹤導管功能、檢測堵塞並監測患者狀況。這些創新使中心靜脈導管更安全、更可靠、更易於管理，從而在全球醫院和診所中廣泛使用。

市場動態和患者人口統計數據將在中心靜脈導管（CVAD）的採用中發揮什麼作用？

慢性疾病（尤其是癌症和腎衰竭）盛行率的不斷上升是推動中心靜脈通路裝置需求成長的主要因素之一。隨著全球人口老化，需要長期靜脈治療的疾病發生率持續上升，使得中心靜脈通路裝置成為現代醫療保健的重要組成部分。例如，在腫瘤領域，癌症診斷率的上升導致中心靜脈通路裝置在化療和其他標靶治療中的應用相應增加。同樣，末期腎功能衰竭患者需要透析治療的人數不斷增加，也推動了中央靜脈導管作為關鍵治療網路基地台的使用。除了慢性疾病，中心靜脈通路裝置在急診護理中也擴大用於快速輸注液體、血液製品和救命藥物。在市場動態方面，先進導管產品的日益普及（尤其是在新興市場）以及醫療基礎設施的不斷完善，也促進了中心靜脈通路裝置的廣泛應用。對微創治療方法的需求，加上病患治療效果的改善，進一步加速了這些裝置在各種醫療保健環境中的應用。

中心靜脈通路裝置市場的成長要素是什麼？

中心靜脈通路裝置市場的成長受到多種因素的驅動，這些因素與不斷變化的醫療需求和技術進步密切相關。癌症、慢性腎臟病和其他需要靜脈輸液治療的長期疾病的日益普遍是主要促進因素。隨著越來越多的患者接受化療、透析和腸外營養等長期治療，對中心靜脈通路裝置的需求也隨之飆升。導管設計的技術進步，特別是抗菌塗層和抗血栓裝置的研發，使這些裝置更加安全耐用，從而促進了其在醫院和診所的應用。此外，超音波引導導管插入技術的廣泛應用，幫助醫護人員更精準地放置這些裝置，從而減少併發症並改善患者預後。另一個關鍵促進因素是對微創和長期治療方案的需求不斷成長，尤其是老年患者和慢性疾病患者。各國政府和醫療機構也積極推動更安全、更有效的醫療設備的應用，這進一步促進了先進中心靜脈通路裝置市場的擴張。此外，發展中地區醫療基礎設施的不斷完善以及人們對中心靜脈通路裝置益處的認知不斷提高，都促進了市場成長。這些因素，加上對加強感染控制和提高患者舒適度的需求，共同推動了全球中心靜脈通路裝置市場的快速擴張。

部分：

透過應用（藥物給藥、液體和營養支持、輸血、診斷和檢測）

受訪公司範例

  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun Medical Ltd.
  • BARD, A Becton, Dickinson Company
  • Medical Components, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Teleflex Inc.
  • Vygon SA

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Global Industry Analysts 並沒有依賴通用的 LLM 或查詢產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

我們最新發布的報告納入了關稅對區域市場的影響，正如全球產業分析師預測的那樣，關稅將改變企業的競爭地位，而企業的競爭地位將取決於其總部所在地、製造地以及進出口（成品和OEM產品）。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP10962

Global Central Venous Access Devices Market to Reach US$2.4 Billion by 2030

The global market for Central Venous Access Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Drug Administration Application, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Fluid & Nutrition Administration Application segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$478.4 Million While China is Forecast to Grow at 7.4% CAGR

The Central Venous Access Devices market in the U.S. is estimated at US$478.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$535.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Central Venous Access Devices Market - Key Trends and Drivers Summarized

Why Are Central Venous Access Devices Crucial in Modern Medical Treatments?

Central Venous Access Devices (CVADs) have become indispensable in modern healthcare, especially for patients requiring long-term intravenous treatments, such as chemotherapy, dialysis, or parenteral nutrition. These devices, which include catheters inserted into large veins like the subclavian or jugular vein, allow for the efficient and consistent delivery of medications, fluids, and other therapies directly into the bloodstream. For patients undergoing cancer treatments, central venous catheters reduce the need for repeated needle insertions, offering a less painful and more convenient solution. The ability to administer high concentrations of medication while reducing the risk of vein irritation makes CVADs particularly valuable in intensive care settings. Their usage has expanded across a variety of medical applications, including the management of chronic diseases, emergency care, and the administration of life-saving treatments, making CVADs an essential tool in modern medical protocols.

How Are Technological Innovations Improving the Safety and Efficiency of CVADs?

Technological advancements have significantly improved the design and functionality of Central Venous Access Devices, enhancing both patient safety and clinical outcomes. One of the most notable innovations is the development of antimicrobial and anti-thrombogenic coatings, which help reduce the risks of catheter-related infections and blood clots, two of the most common complications associated with CVADs. Additionally, advancements in catheter materials, such as silicone and polyurethane, have made these devices more flexible and durable, minimizing the risk of vein damage and ensuring longer device lifespan. Another key innovation is the use of ultrasound guidance for catheter insertion, which has greatly improved the accuracy and safety of CVAD placement. This technology reduces the risk of complications during insertion, such as puncturing arteries or causing pneumothorax, while also shortening the procedure time. Furthermore, the development of devices with integrated sensors and real-time monitoring capabilities has enhanced the ability of healthcare providers to track catheter function, detect blockages, and monitor patient conditions more effectively. These innovations are making CVADs safer, more reliable, and easier to manage, driving their adoption in hospitals and clinics worldwide.

What Role Do Market Dynamics and Patient Demographics Play in CVAD Adoption?

The increasing prevalence of chronic diseases, particularly cancer and renal failure, is one of the key factors driving the growing demand for Central Venous Access Devices. As the global population ages, the incidence of conditions requiring long-term intravenous therapy continues to rise, making CVADs an essential component of modern medical care. In oncology, for instance, the rising number of cancer diagnoses has led to a corresponding increase in the use of CVADs for the administration of chemotherapy and other targeted therapies. Similarly, the growing number of patients requiring dialysis due to end-stage renal disease has driven the use of central venous catheters as a critical access point for treatment. In addition to chronic diseases, CVADs are increasingly used in emergency care settings for the rapid administration of fluids, blood products, and life-saving medications. Market dynamics, including the increasing availability of advanced catheter products and improved healthcare infrastructure, particularly in emerging markets, are also contributing to the rise in CVAD adoption. The demand for minimally invasive treatment options, coupled with improved patient outcomes, is further accelerating the use of these devices across a range of healthcare settings.

What Are the Factors Behind the Growth of Central Venous Access Devices Market?

The growth of the Central Venous Access Devices market is driven by several factors related to evolving medical needs and technological advancements. The rising prevalence of cancer, chronic kidney disease, and other long-term conditions that require intravenous therapies is a significant driver. With more patients undergoing extended treatments like chemotherapy, dialysis, and parenteral nutrition, the demand for CVADs has surged. Technological advancements in catheter design, particularly the development of antimicrobial-coated and anti-thrombogenic devices, have made these devices safer and more durable, driving their adoption across hospitals and clinics. In addition, the increased use of ultrasound-guided catheter insertion techniques has made it easier for healthcare providers to place these devices with higher accuracy, reducing complications and improving patient outcomes. Another major factor is the growing demand for minimally invasive and long-term treatment solutions, particularly among elderly patients and those with chronic conditions. Governments and healthcare providers are also pushing for the adoption of safer, more effective medical devices, further boosting the market for advanced CVADs. Moreover, the expanding healthcare infrastructure in developing regions, along with the increasing awareness of the benefits of CVADs, is contributing to market growth. These factors, combined with the need for better infection control and patient comfort, are fueling the rapid expansion of the global Central Venous Access Devices market.

SCOPE OF STUDY:

The report analyzes the Central Venous Access Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Administration, Fluid & Nutrition Administration, Blood Transfusion, Diagnostics & Testing)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun Medical Ltd.
  • BARD, A Becton, Dickinson Company
  • Medical Components, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Teleflex Inc.
  • Vygon SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Central Venous Access Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Chronic Diseases Propels Growth of Central Venous Access Devices Market
    • Increasing Use of Central Venous Catheters in Chemotherapy Expands Addressable Market for Venous Access Devices
    • Technological Advancements in Catheter Materials Strengthen Business Case for Safer and Longer-Lasting Devices
    • Rising Geriatric Population Spurs Demand for Central Venous Access Devices in Long-Term Care
    • Advancements in Infection Control Technologies Propel Growth in Central Venous Access Devices with Antimicrobial Properties
    • Increasing Use of Central Venous Access Devices in Dialysis and Critical Care Sustains Market Growth
    • Growing Focus on Home Healthcare Throws the Spotlight on Portable and Easy-to-Use Central Venous Access Devices
    • Rising Adoption of Ultrasound-Guided Catheter Insertion Accelerates Demand for Specialized Central Venous Access Devices
    • Increasing Use of Central Venous Access Devices in Pediatric Care Expands Market Potential
    • Focus on Reducing Catheter-Related Complications Strengthens Demand for Advanced Venous Access Devices
    • Rising Prevalence of Cancer and the Need for Long-Term IV Therapies Spur Growth in Central Venous Access Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Central Venous Access Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Central Venous Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drug Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fluid & Nutrition Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fluid & Nutrition Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Fluid & Nutrition Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Blood Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostics & Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostics & Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostics & Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • JAPAN
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • CHINA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • EUROPE
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Central Venous Access Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • FRANCE
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • GERMANY
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Central Venous Access Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • INDIA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Central Venous Access Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Central Venous Access Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Central Venous Access Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030
  • AFRICA
    • Central Venous Access Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Central Venous Access Devices by Application - Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Central Venous Access Devices by Application - Percentage Breakdown of Value Sales for Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing for the Years 2015, 2025 & 2030

IV. COMPETITION